The new research, based on data from more than 600 patients, was presented at ACC.24 in Atlanta and published in the New England Journal of Medicine. Semaglutide is sold by Novo Nordisk under the brand name Wegovy.

"I wasn’t expecting these results among women in this lower age group, because we usually see increased risk for heart disease among older women," one cardiologist said. "It was definitely surprising.”

The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.

Time-restricted eating is popular in the United States, but new research suggests it may do more harm than good if taken to certain extremes. 

Researchers also found that CABG and PCI were each associated with their own advantages and disadvantages, highlighting the importance of shared decision-making. 

Nutritionists view niacin, also known as vitamin B3, as a fundamental part of any diet. Consuming too much, however, could potentially be bad for the heart. 

The Heart Failure Society of America shared a new scientific statement about this topic, noting that many patients may require additional help.

Diet sodas made with artificial sweeteners are associated with an even higher risk of issues than sugar-sweetened sodas.